NCT00374920View on ClinicalTrials.gov

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

March 31, 2007

Conditions
Bipolar Disorder With Manic or Mixed Episodes
Interventions
DRUG

MEM 1003

Trial Locations (21)

19149

Philadelphia

33301

Fort Lauderdale

34208

Bradenton

70601

Lake Charles

71101

Shreveport

72201

Little Rock

75062

Irving

75228

Dallas

77008

Houston

77401

Bellaire

78729

Austin

78745

Austin

78756

Austin

90502

Torrance

92105

San Diego

92506

Riverside

92845

Garden Grove

98033

Kirkland

98034

Kirkland

02114

Boston

08046

Willingboro

Sponsors
All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Memory Pharmaceuticals

INDUSTRY